Pharmamarketeer

New study argues the importance of existing anti-inflammatory drugs in fighting dementia

Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal of Pfizer from the space, among others. But a new study by scientists in Australia has put forward an explanation for why current approaches in the space have failed to produce progress in dementia and Alzheimer’s.

Reageer

Medhc-fases-banner
Advertentie(s)